Paediatric HIV

LIVING Study Phase III

NCT02346487 |  Kenya, Uganda

Lopinavir/ritonavir pellets with dual NRTIs implemenation study in infants and young children.

 

LOLIPOP Study Phase I/II

NCT03836833 | Uganda

Lopinavir/r/ Lamivudine/ Abacavir as an easy-to-use paediatric formulation.

 

Ritonavir superboosting study for TB/HIV Phase IV

NCT02348177  |  South Africa  |  Completed

Pharmacokinetics of lopinavir/ritonavir superboosting in infants and young children co-infected with HIV and TB.

 

Last update: February 2019